Figure 4From: Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancerOverall survival curves for patients classified according to expression of ILK. Five-year survival rates were 20% and 59% for patients in the strong ILK and weak or no ILK groups, respectively. A log-rank test revealed a significant difference between the two groups (p < 0.001).Back to article page